| Trial ID: | L1796 |
| Source ID: | NCT00932048
|
| Associated Drug: |
Atorvastatin
|
| Title: |
Effect of Atorvastatin on Vascular Inflammation in Type 2 Diabetes
|
| Acronym: |
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes|Atherosclerosis
|
| Interventions: |
DRUG: Atorvastatin
|
| Outcome Measures: |
Primary: Vascular inflammation analyzed by PET: Define attenuation of plaque inflammation (plaque SUV or TBR) at 12 weeks, 12 weeks | Secondary: Change in LDL-cholesterol levels after active treatment, 12 weeks|Biomarkers: hs-CRP, adiponectin, MCP-1, PAI-1, TNF-α, IL-6, 12 weeks|Change in carotid plaque thickness by ultrasound, 12 weeks
|
| Sponsor/Collaborators: |
Sponsor: Korea University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
0
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2011-08
|
| Completion Date: |
2012-03
|
| Results First Posted: |
|
| Last Update Posted: |
2013-09-06
|
| Locations: |
Tae Nyun Kim, Seoul, 152-050, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT00932048
|
